MedTrace Logo

The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension

NCT06208904 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2025-03-14

No results posted yet for this study

Summary

The present study investigates the involvement of the gut hormone glucose-dependent insulinotropic polypeptide (GIP) in the pathophysiology of postprandial hypotension (PPH)

Conditions

  • PostPrandial Hypotension

Interventions

OTHER

Intravenous infusion of GIPRA

Intravenous infusion of GIP(3-30)NH2 in a concentration of 1,000 pmol/kg/min during experimental days

OTHER

Intravenous infusion of saline

Intravenous infusion of isotonic saline 9 mg/ml added 0,5% human serum albumin during experimental days

Sponsors & Collaborators

  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Principal Investigators

  • Lise Wilki-Kurtzhals · University Hospital, Gentofte, Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06208904 on ClinicalTrials.gov